The WHO has announced the eleven substances to be reviewed at the upcoming 43rd Expert Committee on Drug Dependence (ECDD) meeting, scheduled for 12th-16th October, have been identified through a prioritization process. 

New psychoactive substances to be reviewed for international control at the 43rd ECDD include the opioid isotonitazene; benzodiazepines flubromazolam, clonazolam, diclazepam; the dissociative drugs diphenidine, 2-MeO-diphenidine, and 3-Meo-PCP; the stimulant 3-FPM; the hallucinogenic substance 5-MeO-DALT; and two synthetic cannabinoids, MDMB-4en-PINACA and CUMYL-PEGACLONE.